Posterior Macular Adhesion: A Potential Risk Factor for Non-exudative Age Related Macular Degeneration (AMD) to Develop Exudative AMD (PAM)
Posterior Macular Adhesion: A Potential Risk Factor for Non-exudative AMD to Develop Exudative AMD
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Ilse Krebs, MD
- Phone Number: 4607 +43171165
- Email: ilse.krebs@wienkav.at
Study Locations
-
-
-
Vienna, Austria, 1030
- Recruiting
- Ludwig Boltzmann Institute for Retinology and Biomicroscopic Lasersurgery
-
Contact:
- Ilse Krebs, MD
- Phone Number: 94682 43-17-1165
- Email: Ilse.Krebs@wienkav.at
-
Sub-Investigator:
- Ilse Krebs, MD
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Dry MD
- Age over 50 years
Exclusion Criteria:
- Macular pathologies other than age related macular degeneration (like diabetic maculopathy, macular pucker, macular hole)
- Prior vitrectomy or buckle surgery
- Uveitis posterior, multifocal chorioiditis
- Pathologic myopia
- Diabetic retinopathy
- Visualization of the macula not possible (dens cataract, vitreous haemorrhage)
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Dry AMD
male or female persons aged over 50 years with dry age-related macular degeneration
|
A-scan and B-scan ultrasound at baseline and month 6,12,24
Volume scans of spectralis OCT at baseline and month 6,12,24
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of eyes with non-exudative AMD with attached and detached posterior vitreous cortex developing exudative AMD
Time Frame: 24 months
|
24 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Distance acuity
Time Frame: 24 months
|
24 months
|
|
Age
Time Frame: 24 months
|
24 months
|
|
Smoking
Time Frame: 24 months
|
24 months
|
|
Obesity
Time Frame: 24 months
|
24 months
|
|
Lesion classification (AREDS)
Time Frame: 24 months
|
24 months
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: Susanne Binder, Prof MD, Ludwig Boltzmann Institute for Retinology and Biomicroscopic Laser Surgery
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 09-052-0409
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.